Share-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 12 Months Ended | |
Feb. 29, 2016 | Aug. 31, 2014 | Jun. 24, 2016 | Jun. 26, 2015 | Jun. 27, 2014 | Oct. 31, 2014 |
Share-Based Benefit Plans: | | | | | | |
Stock awards, term from grant date to expiration | | | 10 years | | | |
Award vesting period (generally) | | | 4 years | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | $ 12,037 | $ 14,549 | $ 11,979 | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Amounts withheld for taxes | | | $ 1,673 | $ 2,482 | $ 2,685 | |
Stock options | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, beginning of period (in shares) | | | 1,386,570 | 1,608,436 | 2,281,401 | |
Options granted (in shares) | | | 0 | 0 | 0 | |
Options exercised (in shares) | | | (26,877) | (69,471) | (492,825) | |
Options cancelled (in shares) | | | (230,790) | (152,395) | (180,140) | |
Options outstanding, end of period (in shares) | | | 1,128,903 | 1,386,570 | 1,608,436 | |
Vested and expected to vest (in shares) | | | 1,128,902 | | | |
Exercisable (in shares) | | | 1,128,402 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, beginning balance, weighted average exercise price (USD per share) | | | $ 10.41 | $ 10.53 | $ 10.56 | |
Options granted, weighted average exercise price (USD per share) | | | 0 | 0 | 0 | |
Options exercised, weighted average exercise price (USD per shares) | | | 5.34 | 5.80 | 7.83 | |
Options cancelled, weighted average exercise price (USD per share) | | | 13.87 | 13.75 | 18.32 | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | 9.82 | $ 10.41 | $ 10.53 | |
Vested and expected to vest, weighted average exercise price (USD per share) | | | 9.82 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 9.82 | | | |
Options outstanding, weighted average remaining contractual term | | | 3 years 10 months 17 days | | | |
Vested and expected to vest, weighted average remaining contractual term | | | 3 years 10 months 17 days | | | |
Exercisable, weighted average remaining contractual term | | | 3 years 10 months 17 days | | | |
Options outstanding, aggregate intrinsic value | | | $ 0 | | | |
Vested and expected to vest, aggregate intrinsic value | | | 0 | | | |
Exercisable, aggregate intrinsic value | | | 0 | | | |
Total intrinsic value of options exercised in period | | | | $ 200 | $ 3,900 | |
Total fair value of shares vested during period | | | $ 1,500 | $ 1,500 | $ 2,500 | |
Exercise price range, lower range limit (USD per share) | | | $ 5.07 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 33.07 | | | |
Stock options | $5.07 - $5.07 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 13,235 | | | |
Exercisable (in shares) | | | 13,235 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.07 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 5.07 | | | |
Options outstanding, weighted average remaining contractual term | | | 2 years 11 months 6 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.07 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 5.07 | | | |
Stock options | $5.34 - $5.34 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 138,217 | | | |
Exercisable (in shares) | | | 138,217 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.34 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 5.34 | | | |
Options outstanding, weighted average remaining contractual term | | | 3 years 49 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.34 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 5.34 | | | |
Stock options | $5.60 - $6.58 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 131,972 | | | |
Exercisable (in shares) | | | 131,555 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 5.83 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 5.83 | | | |
Options outstanding, weighted average remaining contractual term | | | 2 years 3 months 29 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 5.60 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 6.58 | | | |
Stock options | $6.69 - $7.99 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 159,720 | | | |
Exercisable (in shares) | | | 159,636 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 7.78 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 7.79 | | | |
Options outstanding, weighted average remaining contractual term | | | 2 years 10 months 24 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 6.69 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 7.99 | | | |
Stock options | $8.98 - $9.68 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 97,500 | | | |
Exercisable (in shares) | | | 97,500 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 9.06 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 9.06 | | | |
Options outstanding, weighted average remaining contractual term | | | 3 years 3 months 15 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 8.98 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 9.68 | | | |
Stock options | $9.78 - $9.78 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 212,396 | | | |
Exercisable (in shares) | | | 212,396 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 9.78 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 9.78 | | | |
Options outstanding, weighted average remaining contractual term | | | 5 years 8 months 5 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 9.78 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 9.78 | | | |
Stock options | $9.82 - $11.69 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 153,950 | | | |
Exercisable (in shares) | | | 153,950 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 11.06 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 11.06 | | | |
Options outstanding, weighted average remaining contractual term | | | 5 years 11 months 25 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 9.82 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 11.69 | | | |
Stock options | $11.83 - $14.68 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 49,913 | | | |
Exercisable (in shares) | | | 49,913 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 13.47 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 13.47 | | | |
Options outstanding, weighted average remaining contractual term | | | 1 year 8 months 37 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 11.83 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 14.68 | | | |
Stock options | $14.69 - $14.69 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 130,000 | | | |
Exercisable (in shares) | | | 130,000 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 14.69 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 14.69 | | | |
Options outstanding, weighted average remaining contractual term | | | 4 years 1 month 35 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 14.69 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 14.69 | | | |
Stock options | $17.34 - $33.07 | | | | | | |
Options outstanding, shares: | | | | | | |
Options outstanding, end of period (in shares) | | | 42,000 | | | |
Exercisable (in shares) | | | 42,000 | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, ending balance, weighted average exercise price (USD per share) | | | $ 24.42 | | | |
Exercisable, weighted average exercise price (USD per share) | | | $ 24.42 | | | |
Options outstanding, weighted average remaining contractual term | | | 1 year 4 months 5 days | | | |
Exercise price range, lower range limit (USD per share) | | | $ 17.34 | | | |
Exercise price range, upper range limit (USD per share) | | | $ 33.07 | | | |
Restricted stock units (RSUs) | | | | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Options outstanding, weighted average remaining contractual term | | | 1 year 2 months 17 days | | | |
Vested and expected to vest, weighted average remaining contractual term | | | 1 year 20 days | | | |
Total compensation cost related to non-vested awards, period for recognition | | | 1 year 2 months 18 days | | | |
Restricted stock activity, number of shares: | | | | | | |
Equity instruments other than options, outstanding, beginning of period (in shares) | | | 1,706,073 | 1,696,823 | 1,337,767 | |
Awarded (in shares) | | | 1,495,901 | 1,273,510 | 1,237,967 | |
Released (in shares) | | | (997,453) | (804,420) | (558,481) | |
Forfeited (in shares) | | | (279,437) | (459,840) | (320,430) | |
Equity instruments other than options, outstanding, end of period (in shares) | | | 1,925,084 | 1,706,073 | 1,696,823 | |
Equity instruments other than options, vested and expected to vest (in shares) | | | 1,514,695 | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Equity intstruments other than options, outstanding, weighted average grant date fair value, beginning of period (in shares) | | | $ 10.81 | $ 12.67 | $ 10.27 | |
Awarded, weighted average grant date fair value (USD per share) | | | 5.16 | 9.44 | 14.41 | |
Released, weighted average grant date fair value (USD per share) | | | 9.77 | 8.90 | 12.17 | |
Forfeited, weighted average grant date fair value (USD per share) | | | 8.25 | 12.82 | 11.98 | |
Equity intstruments other than options, outstanding, weighted average grant date fair value, end of period (in shares) | | | 7.30 | $ 10.81 | $ 12.67 | |
Equity instruments other than options, vested and expected to vest, weighted average grant date fair value (USD per share) | | | $ 7.37 | | | |
Equity instruments other than options, nonvested, intrinsic value | | | $ 9,626 | | | |
Equity instruments other than options, vested and expected to vest, outstanding, intrinsic value | | | 7,577 | | | |
Total unrecognized compensation cost related to non-vested awards, equity instruments other than options | | | $ 3,700 | | | |
Time-based RSUs | Executive Officer | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Award vesting period (generally) | | 4 years | | | | |
RSUs and RSAs | | | | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Shares withheld for taxes (in shares) | | | 340,284,000 | 278,733,000 | 214,304,000 | |
Amounts withheld for taxes | | | $ 1,673 | $ 2,482 | $ 2,671 | |
Cost of revenue | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 1,622 | 1,962 | 1,676 | |
Research and development | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 2,132 | 2,318 | 2,072 | |
Sales and marketing | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | 1,675 | 2,771 | 2,598 | |
General and administrative | Continuing operations | | | | | | |
Weighted average fair value assumptions: | | | | | | |
Share-based compensation | | | $ 6,608 | $ 7,498 | $ 5,633 | |
Employee Stock Purchase Plan - 2005 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 1,340,017 | | | |
Number of additional shares authorized | | | | 2,000,000 | 365,263 | |
Weighted average fair value assumptions: | | | | | | |
Risk-free interest rate | | | 0.50% | 0.20% | 0.20% | |
Volatility | | | 63.80% | 49.10% | 56.70% | |
Weighted average expected life (in years) | | | 1 year 3 months | 1 year 3 months | 1 year 3 months | |
Expected dividend yield | | | 0.00% | 0.00% | 0.00% | |
Weighted average grant date fair value (USD per share) | | | $ 2.09 | $ 3.23 | $ 5.59 | |
Employee Stock Purchase Plan: | | | | | | |
Shares issued (in shares) | | | 795,208,000 | 457,125,000 | 540,448,000 | |
Weighted-average purchase price per share (USD per share) | | | $ 4.34 | $ 7.58 | $ 7.92 | |
Employee Stock Purchase Plan - 2005 | Employee Stock | | | | | | |
Options outstanding, weighted average exercise price: | | | | | | |
Total compensation cost related to non-vested awards, period for recognition | | | 1 year 7 months 6 days | | | |
Restricted stock activity, weighted average grant date fair value: | | | | | | |
Total unrecognized compensation cost related to non-vested awards, equity instruments other than options | | | $ 1,200 | | | |
Omnibus Incentive Plan - 2014 | | | | | | |
Share-Based Benefit Plans: | | | | | | |
Number of shares available for grant | | | 2,476,931 | | | |
Number of additional shares authorized | 1,200,000 | | | | | |
Number of shares authorized | | | | | | 2,500,000 |